Year-end report conference call February 11 at 11 AM (CET) >>
Read the CEO interview at redeye.se - December 12, 2009 (in Swedish)>>
Meet us at:
AAOS 2010 >>
New
Orleans, United States
March 9 – 13,
2010
Booth no:
5318
Annual report
Five year overview
Amounts in KSEK
2008*
Jan-Dec
2007*
Jan-Dec
2006* Jan-Dec
2005 Jan-Dec
2004 Jan-Dec
Net sales
12,114
16,275
5,571
8,143
4,804
Cost of goods & services sold**
-4,194
-2,603
-616
-482
-921
Gross profit/loss
7,920
13,672
4,955
7,661
3,883
Other income***
1,359
305
263
163
28
Research and development costs**
-15,502
-14,722
-43,177
-26,959
-32,327
Selling costs
-11,688
-9,134
-12,090
-9,608
-8,276
Administrative costs
-5,195
-5,343
-7,183
-8,613
-6,847
Other costs***
-1,209
-408
-298
-77
-18
Operating loss
-24,315
-15,630
-57,530
-37,433
-43,557
Interest income and other
financial income
2,284
2,251
1,841
1,211
1,218
Interest expenses and other
financial expenses
-602
-71
-330
-22
-33
Net financial items
1,682
2,180
1,511
1,189
1,185
Loss after financial items
-22,633
-13,450
-56,019
-36,244
-42,372
Taxes
-
-
-
-
-
Loss for the period
-22,633
-13,450
-56,019
-36,244
-42,372
*
Consolidated financial statements, incl. Artimplant USA, Inc. 2006-2008. The figures for 2004-2005 only cover the Parent Company Artimplant AB.
**
Impairment of product development expenses brought forward are included in 2006 to the amount of KSEK 17,118. Since 2006, depreciation of product development expenses brought forward is reported as R&D. A recalculation has been made for previous years.
***
In 2008, Artimplant switched to reporting Other income och Other costs separately.
A recalculation has been made for previous years.
Amounts in KSEK
2008*
Dec.31
2007*
Dec.31
2006*
Dec. 31
2005
Dec. 31
2004 Dec. 31
Total fixed assets
6,680
10,006
10,214
32,314
37,936
Total current assets
40,309
59,606
72,863
107,702
54,068
of which cash in hand and at the bank
31,371
49,240
68,704
104,186
51,277
Total assets
46,989
69,612
83,077
140,016
92,003
Total restricted equity
64,194
77,913
132,966
168,542
126,020
Total retained loss
-22,229
-13,664
-55,352
-35,696
-42,081
Total equity
41,965
64,249
77,614
132,846
83,939
Total provisions and non-current liabilities
20
52
353
245
-
Total current liabilities
5,004
5,311
5,110
6,925
8,065
Total equity and liabilities
46,989
69,612
83,077
140,016
92,003
*
Consolidated financial statements, incl. Artimplant USA, Inc. 2006-2008. The figures for 2004-2005 only cover the Parent Company Artimplant AB.
Amounts in KSEK
2008* Jan-Dec
2007* Jan-Dec
2006*
Jan-Dec
2005
Jan-Dec
2004 Jan-Dec
Cash flow from operating activities
-17,357
-15,632
-33,190
-28,393
-27,416
Cash flow from investment activities
-590
-3,832
-2,292
-3,301
-3,907
Cash flow from financial activities
-
-
-
84,603
14,650
Cash flow for the year
-17,948
-19,464
-35,482
52,909
-16,673
Liquid assets as of Jan 1
49,240
68,704
104,186
51,277
67,950
Recalculation of foreign liquid assets
79
-
-
-
-
Liquid assets as of Dec 31
31,371
49,240
68,704
104,186
51,277
*
Consolidated financial statements, incl. Artimplant USA, Inc. 2006-2008. The figures for 2004-2005 only cover the Parent Company Artimplant AB.
